Page last updated: 2024-10-26

racemetirosine and Bradykinesia

racemetirosine has been researched along with Bradykinesia in 1 studies

alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)

Research Excerpts

ExcerptRelevanceReference
"In haloperidol-induced catalepsy in rats (1."5.30Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders. ( Cohen, S; Levy, R; Speiser, Z, 1998)
"In haloperidol-induced catalepsy in rats (1."1.30Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders. ( Cohen, S; Levy, R; Speiser, Z, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Speiser, Z1
Levy, R1
Cohen, S1

Other Studies

1 other study available for racemetirosine and Bradykinesia

ArticleYear
Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders.
    Journal of neural transmission. Supplementum, 1998, Volume: 52

    Topics: Aging; alpha-Methyltyrosine; Animals; Avoidance Learning; Catalepsy; Cognition; Cognition Disorders;

1998